The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer

References

• Bernstein CN, Benchimol EI, Bitton A, et al. The impact of inflammatory bowel disease in Canada 2018: extra-intestinal diseases in IBD. J Can Assoc Gastroenterol. 2019;2(Suppl 1):S73–s80. doi:10.1093/jcag/gwy053
   PubMedGoogle Scholar
• Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91–99. doi:10.3748/wjg.v20.i1.91
   PubMed Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi:10.1038/nrgastro.2015.150
   PubMed Web of Science ®Google Scholar
• Wu Y, Qiu W, Xu X, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease in mice through ubiquitination. Am J Transl Res. 2018;10(7):2026–2036.
   PubMed Web of Science ®Google Scholar
• Oerum S, Degut C, Barraud P, Tisne C. m1A post-transcriptional modification in tRNAs. Biomolecules. 2017;7(1):20. doi:10.3390/biom7010020
   PubMed Web of Science ®Google Scholar
• Chen H, Yang H, Zhu X, et al. m(5)C modification of mRNA serves a DNA damage code to promote homologous recombination. Nat Commun. 2020;11(1):2834. doi:10.1038/s41467-020-16722-7
   PubMed Web of Science ®Google Scholar
• Reichel M, Koster T, Staiger D. Marking RNA: m6A writers, readers, and functions in arabidopsis. J Mol Cell Biol. 2019;11(10):899–910. doi:10.1093/jmcb/mjz085
   PubMed Web of Science ®Google Scholar
• Zhang L, Hou C, Chen C, et al. The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs. Mol Cancer. 2020;19(1):105. doi:10.1186/s12943-020-01224-3
   PubMed Web of Science ®Google Scholar
• Chen M, Nie ZY, Wen XH, Gao YH, Cao H, Zhang SF. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer. Biosci Rep. 2019;39(12):12. doi:10.1042/BSR20192892
   Web of Science ®Google Scholar
• Chen M, Wong CM. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer. 2020;19(1):44. doi:10.1186/s12943-020-01172-y
   PubMed Web of Science ®Google Scholar
• Hu BB, Wang XY, Gu XY, et al. N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications. Mol Cancer. 2019;18(1):178. doi:10.1186/s12943-019-1099-7
   PubMed Web of Science ®Google Scholar
• Ni W, Yao S, Zhou Y, et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3. Mol Cancer. 2019;18(1):143. doi:10.1186/s12943-019-1079-y
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu X, Liu L, Li J, Hu Q, Sun R. Expression and prognostic significance of m6a-related genes in lung adenocarcinoma. Med Sci Mon Int Med J Exp Clin Res. 2020;26:e919644.
   Google Scholar
• Lu TX, Zheng Z, Zhang L, et al. A new model of spontaneous colitis in mice induced by deletion of an RNA m(6)A methyltransferase component METTL14 in T cells. Cell Mol Gastroenterol. 2020;10(4):747–761. doi:10.1016/j.jcmgh.2020.07.001
   Web of Science ®Google Scholar
• Tong J, Cao G, Zhang T, et al. m(6)A mRNA methylation sustains treg suppressive functions. Cell Res. 2018;28(2):253–256. doi:10.1038/cr.2018.7
   PubMed Web of Science ®Google Scholar
• Liu ZX, Li LM, Sun HL, Liu SM. Link between m6A modification and cancers. Front Bioeng Biotechnol. 2018;6:89. doi:10.3389/fbioe.2018.00089
   PubMed Web of Science ®Google Scholar
• Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270–288. doi:10.1016/j.ccell.2020.02.004
   PubMed Web of Science ®Google Scholar
• Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201–206. doi:10.1038/nature11112
   PubMed Web of Science ®Google Scholar
• Meyer KD, Patil DP, Zhou J, et al. 5ʹ UTR m(6)A promotes cap-independent translation. Cell. 2015;163(4):999–1010. doi:10.1016/j.cell.2015.10.012
   PubMed Web of Science ®Google Scholar
• Kierzek E, Kierzek R. The thermodynamic stability of RNA duplexes and hairpins containing N6-alkyladenosines and 2-methylthio-N6-alkyladenosines. Nucleic Acids Res. 2003;31(15):4472–4480. doi:10.1093/nar/gkg633
   PubMed Web of Science ®Google Scholar
• Schwartz S, Agarwala SD, Mumbach MR, et al. High-resolution mapping reveals a conserved, widespread, dynamic mRNA methylation program in yeast meiosis. Cell. 2013;155(6):1409–1421. doi:10.1016/j.cell.2013.10.047
   PubMed Web of Science ®Google Scholar
• Geula S, Moshitch-Moshkovitz S, Dominissini D, et al. Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science. 2015;347(6225):1002–1006. doi:10.1126/science.1261417
   PubMed Web of Science ®Google Scholar
• Batista PJ, Molinie B, Wang J, et al. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15(6):707–719. doi:10.1016/j.stem.2014.09.019
   PubMed Web of Science ®Google Scholar
• Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93–95. doi:10.1038/nchembio.1432
   PubMed Web of Science ®Google Scholar
• Schwartz S, Mumbach MR, Jovanovic M, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5ʹ sites. Cell Rep. 2014;8(1):284–296. doi:10.1016/j.celrep.2014.05.048
   PubMed Web of Science ®Google Scholar
• Sorci M, Ianniello Z, Cruciani S, et al. METTL3 regulates WTAP protein homeostasis. Cell Death Dis. 2018;9(8):796. doi:10.1038/s41419-018-0843-z
   PubMedGoogle Scholar
• Patil DP, Chen CK, Pickering BF, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369–373. doi:10.1038/nature19342
   PubMed Web of Science ®Google Scholar
• Pendleton KE, Chen B, Liu K, et al. The U6 snRNA m(6)A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell. 2017;169(5):824–835.e814. doi:10.1016/j.cell.2017.05.003
   PubMed Web of Science ®Google Scholar
• van Tran N, Ernst FGM, Hawley BR, et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res. 2019;47(15):7719–7733. doi:10.1093/nar/gkz619
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885–887. doi:10.1038/nchembio.687
   PubMed Web of Science ®Google Scholar
• Li Y, Wu K, Quan W, et al. The dynamics of FTO binding and demethylation from the m6A motifs. RNA Biol. 2019;16(9):1179–1189. doi:10.1080/15476286.2019.1621120
   PubMed Web of Science ®Google Scholar
• Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18–29. doi:10.1016/j.molcel.2012.10.015
   PubMed Web of Science ®Google Scholar
• Duan HC, Wei LH, Zhang C, et al. ALKBH10B is an RNA N(6)-methyladenosine demethylase affecting Arabidopsis floral transition. Plant Cell. 2017;29(12):2995–3011. doi:10.1105/tpc.16.00912
   PubMed Web of Science ®Google Scholar
• Roundtree IA, Luo GZ, Zhang Z. et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. eLife. 2017:6. doi:10.7554/eLife.31311
   Web of Science ®Google Scholar
• Xiao W, Adhikari S, Dahal U, et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61(4):507–519. doi:10.1016/j.molcel.2016.01.012
   PubMed Web of Science ®Google Scholar
• Kretschmer J, Rao H, Hackert P, Sloan KE, Höbartner C, Bohnsack MT. The m(6)A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5ʹ-3ʹ exoribonuclease XRN1. RNA. 2018;24(10):1339–1350. doi:10.1261/rna.064238.117
   PubMed Web of Science ®Google Scholar
• Mao Y, Dong L, Liu XM, et al. m(6)A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2. Nat Commun. 2019;10(1):5332. doi:10.1038/s41467-019-13317-9
   PubMed Web of Science ®Google Scholar
• Ye J, Wang Z, Chen X, et al. YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation. Theranostics. 2020;10(26):12072–12089. doi:10.7150/thno.51231
   PubMed Web of Science ®Google Scholar
• Fei Q, Zou Z, Roundtree IA, Sun HL, He C. YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators. PLoS Biol. 2020;18(4):e3000664. doi:10.1371/journal.pbio.3000664
   PubMed Web of Science ®Google Scholar
• Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27(3):315–328. doi:10.1038/cr.2017.15
   PubMed Web of Science ®Google Scholar
• Choe J, Lin S, Zhang W, et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature. 2018;561(7724):556–560. doi:10.1038/s41586-018-0538-8
   PubMed Web of Science ®Google Scholar
• Kwon J, Jo YJ, Namgoong S, Kim NH. Functional roles of hnRNPA2/B1 regulated by METTL3 in mammalian embryonic development. Sci Rep. 2019;9(1):8640. doi:10.1038/s41598-019-44714-1
   PubMedGoogle Scholar
• Coker H, Wei G, Brockdorff N. m6A modification of non-coding RNA and the control of mammalian gene expression. Biochim Biophys Acta Gene Regul Mech. 2019;1862(3):310–318. doi:10.1016/j.bbagrm.2018.12.002
   PubMed Web of Science ®Google Scholar
• Yang D, Qiao J, Wang G, et al. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential. Nucleic Acids Res. 2018;46(8):3906–3920. doi:10.1093/nar/gky130
   PubMed Web of Science ®Google Scholar
• Zuo L, Su H, Zhang Q, et al. Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer. Aging. 2021;12.
   PubMedGoogle Scholar
• Liu H, Xu Y, Yao B, Sui T, Lai L, Li Z. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR. Cell Death Dis. 2020;11(8):613. doi:10.1038/s41419-020-02833-y
   PubMed Web of Science ®Google Scholar
• He Y, Hu H, Wang Y, et al. ALKBH5 inhibits pancreatic cancer motility by decreasing long non-coding RNA KCNK15-AS1 methylation. Cell Physiol Biochem. 2018;48(2):838–846. doi:10.1159/000491915
   PubMedGoogle Scholar
• Chen S, Zhou L, Wang Y. ALKBH5-mediated m(6)A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma. Cancer Cell Int. 2020;20:34. doi:10.1186/s12935-020-1105-6
   PubMed Web of Science ®Google Scholar
• Erson-Bensan AE, Begik O. m6A Modification and Implications for microRNAs. Microrna. 2017;6(2):97–101.
   Google Scholar
• Cao G, Li HB, Yin Z, Flavell RA. Recent advances in dynamic m6A RNA modification. Open Biol. 2016;6(4):160003. doi:10.1098/rsob.160003
   PubMed Web of Science ®Google Scholar
• Alarcón CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary microRNAs for processing. Nature. 2015;519(7544):482–485. doi:10.1038/nature14281
   PubMed Web of Science ®Google Scholar
• Hao J, Li C, Lin C, et al. Targeted point mutations of the m6A modification in miR675 using RNA-guided base editing induce cell apoptosis. Biosci Rep. 2020;40(5). doi:10.1042/BSR20192933
   Google Scholar
• Chen T, Hao YJ, Zhang Y, et al. m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency. Cell Stem Cell. 2015;16(3):289–301. doi:10.1016/j.stem.2015.01.016
   PubMed Web of Science ®Google Scholar
• Alarcón CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 is a mediator of m(6) A-dependent nuclear RNA processing events. Cell. 2015;162(6):1299–1308. doi:10.1016/j.cell.2015.08.011
   PubMed Web of Science ®Google Scholar
• Müller S, Glaß M, Singh AK, et al. IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner. Nucleic Acids Res. 2019;47(1):375–390. doi:10.1093/nar/gky1012
   PubMed Web of Science ®Google Scholar
• Jin D, Guo J, Wu Y, et al. m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020;19(1):40. doi:10.1186/s12943-020-01161-1
   PubMed Web of Science ®Google Scholar
• Yang Z, Li J, Feng G, et al. MicroRNA-145 modulates N(6)-methyladenosine levels by targeting the 3ʹ-untranslated mRNA region of the N(6)-methyladenosine binding YTH domain family 2 protein. J Biol Chem. 2017;292(9):3614–3623. doi:10.1074/jbc.M116.749689
   PubMed Web of Science ®Google Scholar
• Han Q, Yang J, Yang H, Li C, Li J, Cao Y. KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p. Cell Cycle. 2020;19(10):1172–1185. doi:10.1080/15384101.2020.1749465
   PubMed Web of Science ®Google Scholar
• Zhou C, Molinie B, Daneshvar K, et al. Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs. Cell Rep. 2017;20(9):2262–2276. doi:10.1016/j.celrep.2017.08.027
   PubMed Web of Science ®Google Scholar
• Di Timoteo G, Dattilo D, Centrón-Broco A, et al. Modulation of circRNA metabolism by m(6)A modification. Cell Rep. 2020;31(6):107641. doi:10.1016/j.celrep.2020.107641
   PubMed Web of Science ®Google Scholar
• Chen YG, Chen R, Ahmad S, et al. N6-methyladenosine modification controls circular RNA immunity. Mol Cell. 2019;76(1):96–109.e109. doi:10.1016/j.molcel.2019.07.016
   PubMed Web of Science ®Google Scholar
• He RZ, Jiang J, Luo DX. M6A modification of circNSUN2 promotes colorectal liver metastasis. Genes Dis. 2021;8(1):6–7. doi:10.1016/j.gendis.2019.12.002
   PubMed Web of Science ®Google Scholar
• Karikó K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23(2):165–175. doi:10.1016/j.immuni.2005.06.008
   PubMed Web of Science ®Google Scholar
• Wang H, Hu X, Huang M, et al. Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation. Nat Commun. 2019;10(1):1898. doi:10.1038/s41467-019-09903-6
   PubMed Web of Science ®Google Scholar
• Wu H, Xu Z, Wang Z, Ren Z, Li L, Ruan Y. Dendritic cells with METTL3 gene knockdown exhibit immature properties and prolong allograft survival. Genes Immun. 2020;21(3):193–202. doi:10.1038/s41435-020-0099-3
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang X, Chen K, et al. CCR7 chemokine receptor-inducible lnc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1α-mediated glycolysis. Immunity. 2019;50(3):600–615.e615. doi:10.1016/j.immuni.2019.01.021
   PubMed Web of Science ®Google Scholar
• Han D, Liu J, Chen C, et al. Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells. Nature. 2019;566(7743):270–274. doi:10.1038/s41586-019-0916-x
   PubMed Web of Science ®Google Scholar
• Li HB, Tong J, Zhu S, et al. m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways. Nature. 2017;548(7667):338–342. doi:10.1038/nature23450
   PubMed Web of Science ®Google Scholar
• Furlan M, Galeota E, de Pretis S, Caselle M, Pelizzola M. m6A-dependent RNA dynamics in T cell differentiation. Genes. 2019;10(1):28. doi:10.3390/genes10010028
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhao Y, Zou L, Zhang D, Aki D, Liu YC. The E3 ligase VHL promotes follicular helper T cell differentiation via glycolytic-epigenetic control. J Exp Med. 2019;216(7):1664–1681. doi:10.1084/jem.20190337
   PubMed Web of Science ®Google Scholar
• Sprent J, Surh CD. Writer’s block: preventing m(6)A mRNA methylation promotes T cell naivety. Immunol Cell Biol. 2017;95(10):855–856. doi:10.1038/icb.2017.67
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao Y, Wang X. et al. Dietary nutrients shape gut microbes and intestinal mucosa via epigenetic modifications. Crit Rev Food Sci Nutr. 2020:1–15. doi:10.1080/10408398.2020.1828813
   Web of Science ®Google Scholar
• Jabs S, Biton A, Bécavin C, et al. Impact of the gut microbiota on the m(6)A epitranscriptome of mouse cecum and liver. Nat Commun. 2020;11(1):1344. doi:10.1038/s41467-020-15126-x
   PubMed Web of Science ®Google Scholar
• Han B, Yan S, Wei S, et al. YTHDF1-mediated translation amplifies Wnt-driven intestinal stemness. EMBO Rep. 2020;21(4):e49229. doi:10.15252/embr.201949229
   PubMed Web of Science ®Google Scholar
• Olazagoitia-Garmendia A, Zhang L, Mera P, et al. Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells. Gut. 2021. doi:10.1136/gutjnl-2020-322566
   PubMed Web of Science ®Google Scholar
• Gan Z, Wei W, Wu J, et al. Resveratrol and curcumin improve intestinal mucosal integrity and decrease m(6)A RNA methylation in the intestine of weaning piglets. ACS Omega. 2019;4(17):17438–17446. doi:10.1021/acsomega.9b02236
   PubMed Web of Science ®Google Scholar
• Song H, Feng X, Zhang H, et al. METTL3 and ALKBH5 oppositely regulate m(6)A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy. 2019;15(8):1419–1437. doi:10.1080/15548627.2019.1586246
   PubMed Web of Science ®Google Scholar
• Song P, Feng L, Li J, et al. β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer. Mol Cancer. 2020;19(1):129.
   PubMed Web of Science ®Google Scholar
• Yue C, Chen J, Li Z, Li L, Chen J, Guo Y. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis. J Exp Clin Cancer Res. 2020;39(1):240. doi:10.1186/s13046-020-01731-7
   PubMed Web of Science ®Google Scholar
• Howell KJ, Kraiczy J, Nayak KM, et al. DNA methylation and transcription patterns in intestinal epithelial cells from pediatric patients with inflammatory bowel diseases differentiate disease subtypes and associate with outcome. Gastroenterology. 2018;154(3):585–598. doi:10.1053/j.gastro.2017.10.007
   PubMed Web of Science ®Google Scholar
• Chen S, Tan WZ, Sutiman N, et al. An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients. Pharmacogenomics J. 2020;20(3):505–515. doi:10.1038/s41397-019-0126-9
   PubMed Web of Science ®Google Scholar
• Kim HS, Cheon JH, Jung ES, et al. A coding variant in FTO confers susceptibility to thiopurine-induced leukopenia in East Asian patients with IBD. Gut. 2017;66(11):1926–1935.
   PubMed Web of Science ®Google Scholar
• Sato T, Takagawa T, Kakuta Y, et al. NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases. Intest Res. 2017;15(3):328–337. doi:10.5217/ir.2017.15.3.328
   PubMedGoogle Scholar
• Zhang C, Wang Y, Peng Y, Xu H, Zhou X. METTL3 regulates inflammatory pain by modulating m(6) A-dependent pri-miR-365-3p processing. FASEB J. 2020;34(1):122–132. doi:10.1096/fj.201901555R
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang M, Ge S, et al. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer. Cancer Med. 2019;8(10):4766–4781. doi:10.1002/cam4.2360
   PubMed Web of Science ®Google Scholar
• Zhang J, Cheng X, Wang J, Huang Y, Yuan J, Guo D. Gene signature and prognostic merit of M6a regulators in colorectal cancer. Exp Biol Med (Maywood). 2020;245(15):1344–1354. doi:10.1177/1535370220936145
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang Q, Zhang M. et al. Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing. Epigenetics. 2020:1–11. doi:10.1080/15592294.2020.1861170
   Web of Science ®Google Scholar
• Liu X, Liu L, Dong Z, et al. Expression patterns and prognostic value of m(6) A-related genes in colorectal cancer. Am J Transl Res. 2019;11(7):3972–3991.
   PubMed Web of Science ®Google Scholar
• Wang S, Fan X, Zhu J, et al. The differentiation of colorectal cancer is closely relevant to m6A modification. Biochem Biophys Res Commun. 2021;546:65–73. doi:10.1016/j.bbrc.2021.02.001
   PubMed Web of Science ®Google Scholar
• Wang L, Hui H, Agrawal K, et al. m(6) A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020;39(20):e104514. doi:10.15252/embj.2020104514
   PubMed Web of Science ®Google Scholar
• Li T, Hu PS, Zuo Z, et al. METTL3 facilitates tumor progression via an m(6) A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18(1):112. doi:10.1186/s12943-019-1038-7
   PubMed Web of Science ®Google Scholar
• Shen C, Xuan B, Yan T, et al. m(6)A-dependent glycolysis enhances colorectal cancer progression. Mol Cancer. 2020;19(1):72. doi:10.1186/s12943-020-01190-w
   PubMed Web of Science ®Google Scholar
• Peng W, Li J, Chen R, et al. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway. J Exp Clin Cancer Res. 2019;38(1):393. doi:10.1186/s13046-019-1408-4
   PubMed Web of Science ®Google Scholar
• Chen H, Gao S, Liu W, et al. RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6) A-GLUT1-mTORC1Axis and is a therapeutic target. Gastroenterology. 2020.
   Web of Science ®Google Scholar
• Zhu W, Si Y, Xu J, et al. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner. J Cell Mol Med. 2020;24(6):3521–3533. doi:10.1111/jcmm.15042
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang S, He C, et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer. 2020;19(1):46. doi:10.1186/s12943-020-1146-4
   PubMed Web of Science ®Google Scholar
• Chen X, Xu M, Xu X, et al. METTL14 suppresses CRC progression via regulating N6-methyladenosine-dependent primary miR-375 processing. Mol Ther. 2020;28(2):599–612. doi:10.1016/j.ymthe.2019.11.016
   PubMed Web of Science ®Google Scholar
• Chen X, Xu M, Xu X, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19(1):106. doi:10.1186/s12943-020-01220-7
   PubMed Web of Science ®Google Scholar
• Kuai D, Zhu S, Shi H, et al. Aberrant expression of m(6)A mRNA methylation regulators in colorectal adenoma and adenocarcinoma. Life Sci. 2021;273:119258. doi:10.1016/j.lfs.2021.119258
   PubMed Web of Science ®Google Scholar
• Bai Y, Yang C, Wu R, et al. YTHDF1 regulates tumorigenicity and cancer stem cell-like activity in human colorectal carcinoma. Front Oncol. 2019;9:332. doi:10.3389/fonc.2019.00332
   PubMed Web of Science ®Google Scholar
• Zuo L, Su H, Zhang Q, et al. Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer. Aging. 2021;13(3):4182–4198. doi:10.18632/aging.202383
   PubMedGoogle Scholar
• Wang Y, Lu JH, Wu QN, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18(1):174. doi:10.1186/s12943-019-1105-0
   PubMed Web of Science ®Google Scholar
• Wu Y, Yang X, Chen Z, et al. m(6)A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1. Mol Cancer. 2019;18(1):87. doi:10.1186/s12943-019-1014-2
   PubMedGoogle Scholar
• Hou P, Meng S, Li M, et al. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification. J Exp Clin Cancer Res. 2021;40(1):52. doi:10.1186/s13046-021-01857-2
   PubMed Web of Science ®Google Scholar
• Sun L, Wan A, Zhou Z, et al. RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer. Gut. 2020. doi:10.1136/gutjnl-2020-320652
   Web of Science ®Google Scholar